Zika virus (ZIKV) is an emerging flavivirus, and its ability to cause birth defects including microcephaly has raised global public health concern. ZIKV is primarily transmitted by the mosquito Aedes aegypti, but it has also been shown to be transmitted sexually from males to their uninfected partners and more recently from females to their uninfected partners. In order to further investigate ZIKV infection of the female reproductive tract and its consequences during pregnancy, we developed the first mouse model of vaginal infection by ZIKV. We find that the vagina is a susceptible route of infection and that vaginal ZIKV infection during pregnancy can lead to growth restriction and resorption of the fetus. We also identify the different components of the type I interferon (IFN) response that control vaginal ZIKV infection. In this proposal, I will use our recently-developed model to investigate how the type I IFN response prevents systemic spread of ZIKV and promotes fetal damage.
My first aim i s to investigate the innate mechanisms that control ZIKV viremia after vaginal infection. We see that mice lacking different components of viral recognition and type I Interferon (IFN) pathway have high levels of local viral replication after vaginal infection. However, only mice lacking the type I IFN receptor (and not some of the transcription factors and sensors upstream of IFN) develop systemic disease, including viremia, brain infection, and death. These findings indicate that there may be different components of the innate immune response control local and systemic ZIKV infection. In this aim, I will investigate how vaginal ZIKV exposure leads to systemic infection and how the immune response prevents systemic spread.
My second aim i s to determine the role of type I IFN signaling in mediating the pathology of the developing placenta and fetus. While type I IFN signaling is clearly important for protecting against spread of ZIKV and other viral infections, we see that type I IFN signaling in fetal-derived tissues mediates the severe pathology reported in ZIKV pregnancy models. In this aim, I will identify the defects in placental and fetal development that result from IFN signaling, and I will identify the cell types and interferon stimulated genes (ISGs) that mediate this damage induced by IFN in the placenta and fetus.
This aim may give insight into how ZIKV and other viral infections lead to pregnancy complications such as intrauterine growth restriction and spontaneous abortion.

Public Health Relevance

Viral infection during pregnancy can have significant impacts on the developing fetus. Zika virus, which has the potential to be sexually transmitted, is an emerging flavivirus that has raised worldwide public health concern for its ability to cause birth defects, including microcephaly, after infection of pregnant women. This project will investigate how the immune system prevents local and systemic spread after sexually-acquired Zika virus infection and how this immune response to viral infections may also mediate damage to the fetus.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #
5F30HD094717-02
Application #
9565949
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Russo, Denise
Project Start
2017-09-16
Project End
2020-09-15
Budget Start
2018-09-16
Budget End
2019-09-15
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Graduate Schools
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Yockey, Laura J; Iwasaki, Akiko (2018) Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development. Immunity 49:397-412
Yockey, Laura J; Jurado, Kellie A; Arora, Nitin et al. (2018) Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol 3: